Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

09/05/2025 07:38

May 9 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
                                    (-100.0 pct)                  
  Operating     loss 785 mln        loss 378 mln                  
  Recurring     loss 810 mln        loss 363 mln                  
  Net           loss 811 mln        loss 364 mln                  
  EPS          loss 32.66 yen      loss 18.24 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T